DEDD, a novel death effector domain-containing protein, targeted to the nucleolus - PubMed (original) (raw)

DEDD, a novel death effector domain-containing protein, targeted to the nucleolus

A H Stegh et al. EMBO J. 1998.

Abstract

The CD95 signaling pathway comprises proteins that contain one or two death effector domains (DED), such as FADD/Mort1 or caspase-8. Here we describe a novel 37 kDa protein, DEDD, that contains an N-terminal DED. DEDD is highly conserved between human and mouse (98. 7% identity) and is ubiquitously expressed. Overexpression of DEDD in 293T cells induced weak apoptosis, mainly through its DED by which it interacts with FADD and caspase-8. Endogenous DEDD was found in the cytoplasm and translocated into the nucleus upon stimulation of CD95. Immunocytological studies revealed that overexpressed DEDD directly translocated into the nucleus, where it co-localizes in the nucleolus with UBF, a basal factor required for RNA polymerase I transcription. Consistent with its nuclear localization, DEDD contains two nuclear localization signals and the C-terminal part shares sequence homology with histones. Recombinant DEDD binds to both DNA and reconstituted mononucleosomes and inhibits transcription in a reconstituted in vitro system. The results suggest that DEDD is a final target of a chain of events by which the CD95-induced apoptotic signal is transferred into the nucleolus to shut off cellular biosynthetic activities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1996 Aug 1;184(2):765-70 - PubMed
    1. Nucleic Acids Res. 1996 Mar 1;24(5):843-9 - PubMed
    1. Nature. 1997 Jul 10;388(6638):190-5 - PubMed
    1. J Biol Chem. 1997 Jul 25;272(30):18542-5 - PubMed
    1. Cell. 1995 May 19;81(4):505-12 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources